APOB and kidney disorder: Cardiovascular biomarkers, such as apolipoprotein B and the apolipoprotein B:A ratio, high-sensitivity C-reactive protein, N-terminal pro-B-type natriuretic peptide and interleukin-6, amongst others, are under investigation.106 There are also novel biomarkers under investigation for nephropathy, which have been recently reviewed elsewhere.107 However, dedicated studies validating these biomarkers in patients with MASLD would be useful.